These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 22115712)

  • 1. Evaluation of dexamethasone phosphate delivered by ocular iontophoresis for treating noninfectious anterior uveitis.
    Cohen AE; Assang C; Patane MA; From S; Korenfeld M;
    Ophthalmology; 2012 Jan; 119(1):66-73. PubMed ID: 22115712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iontophoretic Dexamethasone Phosphate Compared to Topical Prednisolone Acetate 1% for Noninfectious Anterior Segment Uveitis.
    Sheppard J; Garg S; Lievens C; Brandano L; Wirostko B; Korenfeld M; Raizman M; Foster CS
    Am J Ophthalmol; 2020 Mar; 211():76-86. PubMed ID: 31726034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Dexamethasone Sodium Phosphate Treatment (DSP-Visulex) for Noninfectious Anterior Uveitis: A Randomized Phase I/II Clinical Trial.
    Papangkorn K; Truett KR; Vitale AT; Jhaveri C; Scales DK; Foster CS; Montieth A; Higuchi JW; Brar B; Higuchi WI
    Curr Eye Res; 2019 Feb; 44(2):185-193. PubMed ID: 30354530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of ocular and general safety following repeated dosing of dexamethasone phosphate delivered by transscleral iontophoresis in rabbits.
    Patane MA; Schubert W; Sanford T; Gee R; Burgos M; Isom WP; Ruiz-Perez B
    J Ocul Pharmacol Ther; 2013 Oct; 29(8):760-9. PubMed ID: 23844757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dexamethasone Intracameral Drug-Delivery Suspension for Inflammation Associated with Cataract Surgery: A Randomized, Placebo-Controlled, Phase III Trial.
    Donnenfeld E; Holland E
    Ophthalmology; 2018 Jun; 125(6):799-806. PubMed ID: 29397189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ophthalmic Drug Delivery Using Iontophoresis: Recent Clinical Applications.
    Perez VL; Wirostko B; Korenfeld M; From S; Raizman M
    J Ocul Pharmacol Ther; 2020 Mar; 36(2):75-87. PubMed ID: 31755807
    [No Abstract]   [Full Text] [Related]  

  • 7. Phase II results of an intraocular steroid delivery system for cataract surgery.
    Chang DF; Garcia IH; Hunkeler JD; Minas T
    Ophthalmology; 1999 Jun; 106(6):1172-7. PubMed ID: 10366088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iontophoretic delivery of dexamethasone phosphate for non-infectious, non-necrotising anterior scleritis, dose-finding clinical trial.
    O'Neil EC; Huang J; Suhler EB; Dunn JP; Perez VL; Gritz DC; McWilliams K; Peskin E; Ying GS; Bunya VY; Maguire MG; Kempen JH
    Br J Ophthalmol; 2018 Aug; 102(8):1011-1013. PubMed ID: 29666122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized clinical trial of a new dexamethasone delivery system (Surodex) for treatment of post-cataract surgery inflammation.
    Tan DT; Chee SP; Lim L; Lim AS
    Ophthalmology; 1999 Feb; 106(2):223-31. PubMed ID: 9951469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of intravenous secukinumab in noninfectious uveitis requiring steroid-sparing immunosuppressive therapy.
    Letko E; Yeh S; Foster CS; Pleyer U; Brigell M; Grosskreutz CL;
    Ophthalmology; 2015 May; 122(5):939-48. PubMed ID: 25638011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexamethasone posterior-segment drug delivery system in the treatment of macular edema resulting from uveitis or Irvine-Gass syndrome.
    Williams GA; Haller JA; Kuppermann BD; Blumenkranz MS; Weinberg DV; Chou C; Whitcup SM;
    Am J Ophthalmol; 2009 Jun; 147(6):1048-54, 1054.e1-2. PubMed ID: 19268890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of bromfenac ophthalmic solution (Bromday) dosed once daily for postoperative ocular inflammation and pain.
    Henderson BA; Gayton JL; Chandler SP; Gow JA; Klier SM; McNamara TR;
    Ophthalmology; 2011 Nov; 118(11):2120-7. PubMed ID: 21762992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of a dexamethasone anterior segment drug delivery system in patients after phacoemulsification.
    Wadood AC; Armbrecht AM; Aspinall PA; Dhillon B
    J Cataract Refract Surg; 2004 Apr; 30(4):761-8. PubMed ID: 15093636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis.
    Lowder C; Belfort R; Lightman S; Foster CS; Robinson MR; Schiffman RM; Li XY; Cui H; Whitcup SM;
    Arch Ophthalmol; 2011 May; 129(5):545-53. PubMed ID: 21220619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iontophoretic administration of dexamethasone sodium phosphate for acute epicondylitis. A randomized, double-blinded, placebo-controlled study.
    Nirschl RP; Rodin DM; Ochiai DH; Maartmann-Moe C;
    Am J Sports Med; 2003; 31(2):189-95. PubMed ID: 12642251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Difluprednate 0.05% versus prednisolone acetate 1% for endogenous anterior uveitis: a phase III, multicenter, randomized study.
    Sheppard JD; Toyos MM; Kempen JH; Kaur P; Foster CS
    Invest Ophthalmol Vis Sci; 2014 May; 55(5):2993-3002. PubMed ID: 24677110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of loteprednol etabonate 0.5% gel in the treatment of ocular inflammation and pain after cataract surgery.
    Rajpal RK; Roel L; Siou-Mermet R; Erb T
    J Cataract Refract Surg; 2013 Feb; 39(2):158-67. PubMed ID: 23218817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicenter randomized phase 3 study of a sustained-release intracanalicular dexamethasone insert for treatment of ocular inflammation and pain after cataract surgery.
    Tyson SL; Bafna S; Gira JP; Goldberg DF; Jones JJ; Jones MP; Kim JK; Martel JM; Nordlund ML; Piovanetti-Perez IK; Singh IP; Metzinger JL; Mulani D; Sane S; Talamo JH; Goldstein MH;
    J Cataract Refract Surg; 2019 Feb; 45(2):204-212. PubMed ID: 30367938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nepafenac 0.1% plus dexamethasone 0.1% versus dexamethasone alone: effect on macular swelling after cataract surgery.
    Zaczek A; Artzen D; Laurell CG; Stenevi U; Montan P
    J Cataract Refract Surg; 2014 Sep; 40(9):1498-505. PubMed ID: 25135542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edema.
    Kuppermann BD; Blumenkranz MS; Haller JA; Williams GA; Weinberg DV; Chou C; Whitcup SM;
    Arch Ophthalmol; 2007 Mar; 125(3):309-17. PubMed ID: 17353400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.